CABALETTA BIO, INC. (CABA) Social Stream
CABALETTA BIO INC (CABA) Price Targets From Analysts
Use the tables below to see what analysts covering CABALETTA BIO INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 6 | $22 | $20 | $21.25 | $23.94 | -11.24% |
| 2021-12-08 | 6 | $22 | $17 | $20.4 | $23.94 | -14.79% |
| 2021-12-14 | 6 | $22 | $15 | $19.4 | $23.94 | -18.96% |
| 2021-12-15 | 6 | $22 | $15 | $18.6 | $23.94 | -22.31% |
| 2022-05-16 | 6 | $22 | $11 | $16.4 | $23.94 | -31.5% |
| 2022-05-26 | 5 | $17 | $10 | $14 | $23.94 | -41.52% |
| 2022-08-15 | 5 | $17 | $10 | $13.2 | $23.94 | -44.86% |
| 2022-08-22 | 6 | $17 | $10 | $13.2 | $23.94 | -44.86% |
| 2022-08-30 | 6 | $17 | $3 | $10.8 | $23.94 | -54.89% |
| 2022-09-14 | 6 | $13 | $3 | $8.2 | $23.94 | -65.75% |
| 2022-11-14 | 6 | $12 | $3 | $8 | $23.94 | -66.58% |
| 2023-01-03 | 6 | $14 | $3 | $10 | $23.94 | -58.23% |
| 2023-01-27 | 6 | $16 | $10 | $12.6 | $23.94 | -47.37% |
| 2023-05-12 | 6 | $16 | $10 | $13.4 | $23.94 | -44.03% |
| 2023-08-11 | 7 | $34 | $10 | $16.833 | $23.94 | -29.69% |
| 2023-09-05 | 6 | $34 | $14 | $20.6 | $23.94 | -13.95% |
| 2023-09-18 | 6 | $39 | $16 | $25.6 | $23.94 | 6.93% |
| 2023-10-20 | 7 | $39 | $16 | $26.5 | $23.94 | 10.69% |
| 2023-10-25 | 8 | $40 | $16 | $28.428 | $23.94 | 18.75% |
| 2023-11-10 | 8 | $40 | $17 | $30.142 | $23.94 | 25.91% |
| 2023-11-15 | 8 | $50 | $22 | $32 | $23.94 | 33.67% |
| 2023-11-28 | 9 | $50 | $22 | $31.571 | $23.94 | 31.88% |
| 2023-11-29 | 9 | $50 | $22 | $32.375 | $23.94 | 35.23% |
| 2023-12-19 | 9 | $50 | $22 | $33.125 | $23.94 | 38.37% |
The Trend in the Analyst Price Target
CABA's average price target has moved up $23.12 over the prior 50 weeks.
CABA reports an average of 53.47% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-01-27 | 6 | 16 | 10 | 12.600 | 11.86 | 6.24% |
| 2023-08-11 | 6 | 34 | 10 | 16.833 | 13.62 | 23.59% |
| 2023-08-11 | 7 | 34 | 14 | 20.250 | 13.62 | 48.68% |
| 2023-08-11 | 6 | 34 | 14 | 20.250 | 13.62 | 48.68% |
| 2023-08-11 | 5 | 34 | 14 | 20.250 | 13.62 | 48.68% |
CABA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 9 | 0 | 0 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
CABA's average broker recommendation rating improved by 0.33 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, CABALETTA BIO INC's upside potential (average analyst target price relative to current price) is greater than 629.4% of them.
- CABALETTA BIO INC's variance in analysts' estimates is lower than -2156.87% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, CABALETTA BIO INC's number of analysts covering the stock is greater than 2415.6% of them.
- In terms of how CABALETTA BIO INC fares relative to Healthcare stocks, note that its average analyst price target is higher than 1066.54% of that group.
In the Pharmaceutical Products industry, AVRO, MGTX, and BCLI are the three stocks most similar to CABALETTA BIO INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CABA a Buy, Hold or Sell? See the POWR Ratings now!